To monitor therapeutic transgene expression, we developed fusion genes of enhanced green fluorescent protein (EGFP) with two different prodrug-activating enzyme genes: herpes simplex virus type 1 thymidine kinase (HSV-tk) and rabbit cytochrome P450 4B1 (cyp4b1). Expression of the resulting fusion proteins, TK-EGFP and 4B1-EGFP, rendered transduced human and rodent glioma cells sensitive to cytotoxic treatment with the corresponding prodrugs ganciclovir and 4-ipomeanol. Ganciclovir and 4-ipomeanol sensitivity was comparable with that achieved with the native HSV-TK and CYP4B1 proteins. As shown by fluorescence microscopy, TK-EGFP was expressed predominantly intranuclearly, whereas 4B1-EGFP was detectable in the cytoplasm, thereby displaying the orthotopic subcellular distribution of the corresponding native enzymes. The fluorescence intensity correlated well with the corresponding prodrug sensitivity, as shown by fluorescence-activated cell sorter analysis. EGFP expression was also used for the selection of stably HSV-tk-transduced cells by flow cytometric cell sorting. Resulting cell populations showed a homogeneity of fluorescence intensity similar to single-cell clones after antibiotic selection. In conclusion, tk-egfp and 4b1-egfp fusion genes are valuable tools for monitoring prodrug-activating gene therapy in living cells. EGFP fusion genes/proteins provide a simple and reproducible means for the detection, selection, and characterization of cells expressing enzyme genes for prodrug activation.
P rodrug-activating gene therapy is based on the transduction of tumor cells with "suicide" genes encoding for prodrug-activating enzymes that render target cells susceptible to prodrug treatment. 1 The most commonly used enzyme gene is the herpes simplex virus type 1 thymidine kinase gene (HSV-tk). 2 The corresponding enzyme, HSV-TK, converts the nucleoside analog ganciclovir (GCV) into a toxic metabolite and allows selective elimination of HSV-tk-transduced cells both in vitro and in vivo. Various clinical gene therapy trials with virus vector-mediated HSV-tk gene transfer in combination with GCV treatment have already been performed. 3 In contrast, little is known about the rabbit cytochrome P450 4B1 gene (cyp4b1) as a prodrug-activating gene therapy system. The encoded enzyme, CYP4B1, converts the prodrug 4-ipomeanol (4-IM), a naturally occurring substituted furane from Fusarium solani 4, 5 into a potent cytotoxic furane epoxide. The cyp4b1/4-IM system has already been studied as a gene therapy approach for brain tumors. Cell culture and in vivo experiments in nude mice with rodent and human glioma cells demonstrated high cytotoxic activity of the expressed transgene in combination with 2-aminoanthracene or 4-IM treatment. 5, 6 One of the major pitfalls in experimental gene therapy is the lack of proper imaging and visualization techniques to monitor the delivery and distribution of therapeutic transgenes in living cells. For gene-transfer analysis in prokaryotic and mammalian cells, enhanced green fluorescent protein (EGFP) has been proven as a useful reporter tool 7, 8 for providing information about gene expression on a cellular level. However, currently, the feasibility of EGFP is mostly restricted to in vitro studies. For gene expression studies in prodrug-activating gene therapy, fusion genes of egfp with HSV-tk have been generated. For these constructs, preservation of the GCV sensitivity and 1-(2-deoxy-2-fluoro-␤-d-arabinofuranosyl)-5-iodouracil activity of HSV-TK as well as the fluorescence of EGFP was reported. 9, 10 In addi-tion, we generated a cyp4b1-egfp fusion gene that also displayed both the bioactivating capability of CYP4B1 and green fluorescence.
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The aim of the present study was to investigate how EGFP fusion proteins of prodrug-activating enzymes can be used to facilitate and improve experimental work in the field of prodrug-activating gene therapy. For this purpose, we generated egfp fusion genes of HSV-tk and cyp4b1 and studied their properties in cell culture experiments. Our data demonstrated a direct correlation between the marker gene function of egfp and the cytotoxic activity of the enzyme genes. Application of fluorescence-activated cell sorter (FACS) techniques allowed simple and time-saving selection and analysis of transient and stable cell clones expressing HSV-tk or cyp4b1.
MATERIALS AND METHODS

Fusion protein and plasmid construction
cDNA for HSV-tk was obtained from the plasmid NTK 12 and cloned into the pBluescript cloning vector (Stratagene, Heidelberg, Germany) with BglII/BamHI and ClaI sites. The resulting plasmid, pBS-tk, was used as polymerase chain reaction template for generation of the HSV-tk open reading frame without stop codons, but with newly introduced restriction sites for NcoI at the 5Ј and BamHI at the 3Ј end. The resulting 1130-bp polymerase chain reaction fragment was cloned into the plasmid pCR2.1 (Invitrogen, Groningen, The Netherlands). The XhoI/BamHI HSV-tk fragment from pCR2.1-tk was fused in frame to the N terminus of egfp of plasmid pEGFP-N1 (Clontech, Heidelberg, Germany), and the resulting mammalian expression vector was designated ptkegfp. The retroviral vector pBABE-tk-egfp was generated by cloning the HindIII/NotI tk-egfp fragment from ptk-egfp into the HindIII/ClaI sites of pBABEpuro 13 using a NotI linker. Plasmid p4b1-egfp has been described previously. 11 
Cell culture
The rat 9L gliosarcoma cell line 14 was obtained from the University of California-San Francisco Brain Tumor Therapy Center (San Francisco, Calif); the human glioma cell line U87 MG and the TK-negative mouse cell line LMTK Ϫ were supplied by the American Type Culture Collection (Manassas, Va).
9L cells were grown in RPMI 1640 (Biochrom KG, Berlin, Germany) with 1 mM sodium pyruvate (Biochrom), 2 mM glutamine (Biochrom), and 10% fetal calf serum (Biochrom). LMTK Ϫ and U87 cells were cultured in Dulbecco's modified Eagle's medium (Biochrom) with 4.5 mM glucose, 1 mM glutamine, and 10% fetal calf serum. All cell lines were maintained at 37°C and 5% CO 2 .
Stable 9L-TK-EGFP clones were generated by transfecting 9L cells with ptk-egfp using Fugene 6 transfection reagent (Boehringer Mannheim, Mannheim, Germany) and by subsequent G418 selection (1 mg/mL) (Life Technologies, Eggenstein, Germany). Stable transfectants displaying the brightest green fluorescence intensity were further selected by FACS using a FACStar Plus (Becton Dickinson, Heidelberg, Germany). Generation of single-cell clones was then achieved by limiting dilution. U87 cell clones expressing the fusion protein 4B1-EGFP (U87-4B1-EGFP) were generated as described previously. 11 Negative control cell clones were generated by the transfection of native U87 cells with a fusion gene-free control plasmid (pVIC). LMTK Ϫ cells were transfected with pBABE-tk-egfp with Fugene 6 transfection reagent. HSV-TKpositive cells were selected by growth in culture medium containing hypoxanthine/aminopterin/thymidine (HAT) (Life Technologies).
Western blotting
9L, 9L-TK-EGFP, U87, and U87-4B1-EGFP cells were trypsinized, washed with phosphate-buffered saline (PBS) (Serag-Wiessner, Naila, Germany), and lysed in 1ϫ sodium dodecyl sulfate (SDS) gel-loading buffer (50 mM tris(hydroxymethyl)aminomethane/Cl (pH 6.8), 100 mM dithiothreitol, 2% SDS, 0,1% bromophenol blue, and 10% glycerol). Electrophoresis of each cell lysate was performed with an 8% SDS-polyacrylamide gel in a Laemmli buffer system. 15 Proteins were subsequently blotted onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) using standard techniques. 16 After blocking with PBS containing 5% nonfat dry milk (Santa Cruz Biotechnology, Heidelberg, Germany), the membrane was incubated for 1 hour at room temperature with an anti-GFP polyclonal rabbit antiserum (Clontech; diluted 1/1000 in PBS containing 5% nonfat dry milk) or with an anti-HSV-TK polyclonal rabbit antiserum (a kind gift of Dr. W. Summers, Yale University School of Medicine, New Haven, Conn; diluted 1/4000 in PBS containing 5% nonfat dry milk). After washing with PBS/0.1% Tween (Sigma, Deisenhofen, Germany), membranes were incubated for 1 hour at room temperature with a secondary antibody, a goat antirabbit immunoglobulin G serum conjugated with horseradish peroxidase (Santa Cruz Biotechnology; diluted 1/1000 in PBS containing 5% nonfat dry milk). Membranes were washed again with PBS/0.1% Tween, and protein bands were visualized with the enhanced chemiluminescence detection method according to the manufacturer's guidelines (Amersham, Little Chalfont, UK). Exposure times of membranes on x-ray films (Biomax MR-1; Eastman Kodak, Rochester, NY) ranged from 30 to 60 seconds. X-ray films were automatically developed.
Fluorescence microscopy 9L-TK-EGFP and U87-4B1-EGFP cells were grown to 70 -80% confluence. After removal of medium, cells were covered with a cover slide. Fluorescence microscopy was performed with a fluorescence microscope (Axiovert; Carl Zeiss, Oberkochen, Germany) equipped with a 470-nm filter.
Flow cytometry and FACS
A FACStar
Plus or FACScan (Becton Dickinson) with 488-nm argon ion laser excitation was used for the collection of forward scatter, side scatter, EGFP fluorescence, and propidium iodide (PI) fluorescence. Data of 1 ϫ 10 4 of EGFPexpressing cells as well as untransfected native cells were collected and analyzed on an Apple Power Macintosh G3 with CellQuest software (Becton Dickinson). Gates were set on forward scatter, side scatter, and PI (0.4 g/mL) staining to exclude noncellular particles and PI-positive, dead cells. Cells were sorted with a FACStar
Plus to obtain a homogeneous population of EGFP-positive cells.
Cell proliferation assays
To evaluate the cytotoxicity of GCV treatment, 9L-TK-EGFP cells were plated in duplicate at a density of 2 ϫ 10 5 cells/ 100-mm Petri dish and incubated for 5 days in medium containing varying concentrations of GCV (Cymevene; Syntex, Aachen, Germany). Cells were then trypsinized and counted with a Coulter counter ZM (Coulter, Krefeld, Germany). The therapeutic effect at each given GCV dose was demonstrated as relative cell survival (ratio of surviving cell numbers after treatment and without treatment).
To evaluate the cytotoxicity of 4-IM treatment, U87-4B1-EGFP cells were plated in 6-well plates at a density of 1 ϫ 10 5 cells/well and incubated with different concentrations of the prodrug 4-IM for 48 hours. The therapeutic effect was again demonstrated by relative cell survival as described above.
RESULTS
Vector constructs with tk-egfp and 4b1-egfp fusion genes For improved monitoring of therapeutic transgene expression, we generated several plasmids with fusion genes of egfp and two different prodrug-activating enzyme genes: HSV-tk and cyp4B1. The resulting mammalian expression vectors (ptk-egfp and p4b1-egfp) and retroviral vector (pBABE-tk-egfp) with tk-egfp or 4b1-egfp fusion genes are shown in Figure 1 . 
Immunoblot analysis of TK-EGFP and 4B1-EGFP fusion proteins
Immunochemical studies confirmed adequate molecular masses of the resulting fusion proteins in lysates of 9L and U87 cells stably transfected with ptk-egfp or p4b1-egfp (Fig 2) . In lysates of 9L-TK-EGFP cells, staining with an anti-GFP as well as an anti-HSV-TK antiserum revealed a protein band at a molecular mass of ϳ70 kDa (Fig 2, lanes 2 and 4) ; this band represents the adequate molecular mass of the TK-EGFP fusion protein. By staining with anti-GFP, a markedly weaker second band was found at ϳ45 kDa (Fig 2, lane 2) . The significance of this band is not clear; it might correspond to a degradation product of the fusion protein. Immunochemistry of U87-4B1-EGFP cell lysates with the anti-GFP antiserum (Fig 2, lane 6 ) resulted in staining of a protein band at ϳ75 kDa, which is the appropriate molecular mass of the 4B1-EGFP fusion protein. Lysates of native, nontransduced 9L cells (Fig 2, lanes 1 and 3) and U87 cells (Fig 2, lane 5 ) displayed no immunoreaction upon p4b1-egfp (B) carrying the egfp fusion genes under the control of the cytomegalovirus immediate early promoter (pCMV). For selection of stably transfected cells, the plasmids include a neomycin resistance gene under the control of the simian virus 40 promoter (pSV40). The retrovirus vector pBABE-tk-egfp (C) was generated by replacing the puromycin resistance gene of pBABEpuro 16 with the tk-egfp fusion gene. This vector contains retrovirus 5Ј and 3Ј long terminal repeats (LTRs) and a packaging signal (). 3) and U87 cells (lane 5) were separated by SDS-polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. For detection of both fusion proteins, lanes 1, 2, 5, and 6 were incubated with an anti-GFP antiserum. In addition, an anti-HSV-TK antiserum was used for detection of HSV-TK-EGFP (lanes 3 and 4) . (Fig 2, lane 1) or anti-GFP (Fig 2, lanes 3 and 5) staining.
anti-HSV-TK
Fluorescence microscopy of TK-EGFP-and 4B1-EGFPexpressing glioma cells
Subcellular distribution of green fluorescence was investigated by fluorescence microscopy in 9L and U87 cells stably expressing the EGFP fusion proteins. For both fusion proteins, distribution of fluorescence correlated well with the known cellular localization of native HSV-TK and CYP4B1 enzymes. Figure 3A demonstrates that the green fluorescence found in TK-EGFPexpressing 9L cells is located predominantly in the nucleus, where TK activity is usually found. The green fluorescence in U87-4B1-EGFP cells is found in the cytoplasm and correlates with the localization of native CYP4B1 in the rough endoplasmic reticulum/microsomes (Fig 3B) .
FACS-mediated selection of stable TK-EGFP-expressing cell clones
To study drug sensitivity after the transfer of enzyme genes, stably expressing cell clones have to be selected. To facilitate and accelerate the selection of such stably transduced clones, we investigated whether the use of egfp fusion genes can be of some advantage. Thus, for the generation of 9L-TK-EGFP clones, various selection methods were applied after the transfection of 9L cells with ptk-egfp. The resulting cell clones were evaluated for purity and for the amount of fusion gene expression as determined by FACS analysis of green fluorescence. Exploiting neomycin resistance by G418 treatment over 14 days, only 65% of cells displayed green fluorescence after selection. EGFP expression was heterogeneous, with a mean fluorescence intensity (MFI) that was within the EGFP-positive fraction of 88 (Fig 4A) . Subsequent cell sorting for EGFP-high-positive cells provided a relatively homogeneous cell population of ϳ97% green fluorescent cells and an MFI of 347 (Fig 4B) . This result was not significantly improved by additional single-cell clone selection of sorted EGFP-high-positive cells with limiting dilutions. A representative single-cell clone ( Fig  4C) displayed ϳ100% EGFP expression with an MFI of 206. To compare the efficiency of EGFP-based selection with another selection method exploiting HSV-TK activity, pBABE-tk-egfp-transfected LMTK Ϫ cells were selected in HAT medium. As shown by FACS analysis, 93% of cells were EGFP-positive with an MFI of 120 (Fig 4D) .
Correlation of fluorescence intensity and prodrug sensitivity in TK-EGFP-and 4B1-EGFP-expressing glioma cells
To study enzyme gene activity in correlation with EGFP expression, we analyzed several 9L-TK-EGFP and U87-4B1-EGFP single-cell clones for GCV or 4-IM sensitivity and EGFP MFI. As shown in Figure 5A , EGFP MFI correlated well with GCV sensitivity: the most sensitive 9L-TK-EGFP clone displayed the strongest green fluorescence, and the least sensitive one had the lowest EGFP MFI. A similar correlation was found between 4-IM sensitivity and EGFP MFI in different U87-4B1-EGFP clones (Fig 5B) .
DISCUSSION
The objective of the work presented here was to provide a simple and reproducible means for the detection, selection, and characterization of cells transduced with enzyme genes for prodrug activation. Therefore, we generated two different egfp fusion genes with HSV-tk (tk-egfp) and cyp4b1 (4b1-egfp). Transfection of rodent and human glioma cells with tk-egfp or 4b1-egfp resulted in a significant increase in sensitivity to the corresponding prodrugs (Fig 5) and simultaneous green fluorescence as demonstrated by FACS analysis (Fig 4) or fluorescence microscopy (Fig 3) . The expression of fusion proteins was also confirmed by Western blot analysis, which showed adequate molecular masses for both TK-EGFP and 4B1-EGFP (Fig 2) .
The subcellular distribution of HSV-TK and CYP4B1 was investigated by fluorescence microscopy. To date, only a few studies have dealt with this issue. One study localized HSV-specific TK activity in isolated fractions of chromatin and nuclear membranes of virus-infected cells. 17 Another study described a mostly cytoplasmic distribution. 18 In 9L-TK-EGFP cells, we observed that the TK-EGFP fusion protein was expressed predominantly in the nucleus and, at significantly lower levels, also within the cytoplasm. The cytoplasmic expression of the 4B1-EGFP fusion protein in U87 cells corresponded well to the natural localization of CYP4B1. This enzyme is found in the rough endoplasmic reticulum because of the presence of a microsomal localization signal in its DNA sequence. This signal was preserved within the cDNA used for fusion gene construction. 19 FACS-mediated cell selection of egfp and other transgene-coexpressing cells has already been performed in several studies, mostly after cotransfection or infection with bicistronic retroviral vectors. 20, 21 To date, only one study demonstrated highly efficient selection of mammalian cell lines by FACS of cells expressing an EGFP fusion protein. 22 In the present study, we investigated whether the green fluorescence of our TK-EGFP fusion protein can also be exploited for a simpler and faster selection of stably transfected cell clones than standard selection with antibiotics. Therefore, we transfected 9L gliosarcoma cells with ptk-egfp and selected under var- ious conditions for stably EGFP-expressing cell clones. Antibiotic selection based on cotransfer of the G418/ neomycin resistance gene within the expression vector resulted in highly heterogeneous cell populations with a significant fraction of EGFP-negative cells. This may be due to random linearization of the integrating vector plasmid with subsequent loss of egfp coding sequences. Usually, in addition to antibiotic selection, single-cell clones have to be isolated and checked for transgene expression. This method is time-consuming, and there is always a high probability of false-positive clones. Thus, we modified this procedure using FACS after antibiotic selection. The resulting cell clones showed homogeneous EGFP expression with high MFIs similar to EGFP-expressing single-cell clones. However, FACSmediated selection was less time-consuming and more reliable, with nearly no false-positive clones. Interestingly, stable selection by exploitation of HSV-TK activity in LMTK Ϫ cells under HAT medium conditions generated cell clones that displayed a lower purity and higher nonhomogeneity of green fluorescence than combined antibiotic selection and flow cytometric cell sorting. Because the enzymatic activity of HSV-TK was coupled to EGFP within the fusion protein, we expected that HAT selection of HSV-TK-positive cells would result in a nearly 100% EGFP-expressing population. The observation that only 93% of the cells displayed green fluorescence also may be due to plasmid linearization within the fusion gene, resulting in a loss of egfp but not of HSV-tk coding sequences.
Finally, we also investigated whether there is a positive correlation between MFI and prodrug sensitivity for the two fusion proteins. For this purpose, 9L-TK-EGFP and U87-4B1-EGFP clones with various EGFP MFIs were analyzed for GCV and 4-IM sensitivity. As shown in Figure 5 , the highest EGFP MFIs corresponded well with the strongest GCV or 4-IM sensitivity; the lowest MFIs were found in clones displaying the weakest prodrug sensitivity.
In conclusion, the present study indicates that TK-EGFP and 4B1-EGFP fusion proteins essentially retain all of the activities of the single protein components. Subcellular distribution as well as prodrug sensitivity and green fluorescence are not altered by our fusion gene constructs. Fluorescence microscopy and FACS analysis are valuable tools for monitoring the transduction efficiencies for tk-egfp and 4b1-egfp fusion genes. FACSmediated cell selection has also been proven to be an effective and time-saving method for the generation of cell lines stably expressing TK-EGFP or 4B1-EGFP. Furthermore, prodrug sensitivity correlates well with green fluorescence. Thus, determination of fluorescence intensity may indicate the corresponding enzyme activity. This observation may help to easily identify cell lines and tumor types that are resistant to prodrug-activating gene therapy. 
